Posted inBusiness Insights Novartis Shares Drop Following Del-Desiran Drug Trial Disappointment Novartis experiences a significant share price decline after disappointing results from the del-desiran clinical trial and recent setbacks. Posted by Prasenjit Bhowmik November 10, 2026
